Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding

Circ Res. 2017 Oct 27;121(10):1133-1135. doi: 10.1161/CIRCRESAHA.117.312012.

¹ From the Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Australia (J.D.M., K.P.); and Department of Medicine (J.D.M., K.P.), Department of Immunology (K.P.), Department of Clinical Haematology, Alfred Hospital (J.D.M.), and Heart Centre, Alfred Hospital (K.P.), Monash University, Melbourne, Australia.
² From the Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Australia (J.D.M., K.P.); and Department of Medicine (J.D.M., K.P.), Department of Immunology (K.P.), Department of Clinical Haematology, Alfred Hospital (J.D.M.), and Heart Centre, Alfred Hospital (K.P.), Monash University, Melbourne, Australia. karlheinz.peter@baker.edu.au.

No abstract available

Keywords: acute coronary syndromes; anticoagulants; aspirin; fibrin; hemorrhage; platelets; thrombosis.

Publication types